Free & confidential case reviews · No obligation (877) 342-6154

Home / Cases / Elmiron

Prescription DrugLimited intake

Elmiron Vision Loss Lawsuit

Took Elmiron for interstitial cystitis and now have vision problems? Find out if you qualify.

StatusLimited intake
Case typePrescription Drug
Case reviewFree & confidential
Last updatedNovember 2026

About this case

Elmiron (pentosan polysulfate sodium) is prescribed for interstitial cystitis and bladder pain. In June 2020 the label was updated to warn of retinal pigmentary changes. Lawsuits claim the manufacturer, Janssen, failed to warn patients sooner about the risk of permanent eye damage.

Where the case stands

Most Elmiron cases have been resolved through confidential settlements and the federal litigation is winding down. Some attorneys still review claims with a documented diagnosis such as pigmentary maculopathy.

Status last reviewed November 2026. Lawsuit developments change often.

Who may qualify

  • You took Elmiron, typically for a year or longer
  • You were diagnosed with an eye condition such as pigmentary maculopathy or retinal damage
  • Your claim is within your state's filing deadline

Injuries and conditions involved

Pigmentary maculopathyRetinal damageMacular degenerationBlurred or distorted visionDifficulty seeing in low lightVision loss
Do not stop taking any prescribed medication without first consulting your doctor.

Free · Confidential · About 2 minutes

Find out if you qualify

Answer a few quick questions about your Elmiron claim. There's no cost and no obligation.

See If I Qualify

Prefer to talk? Call (877) 342-6154

Free Case Review